Artelo Biosciences Reports Third Quarter Fiscal Year 2020 Financial Results and Provides Business Update
LA JOLLA, Calif., July 14, 2020 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused […]